Albumin-bound protein/peptide complex as a biomarker for disease

Risk factors and prediction of myocardial infarction

THERAPEUTIC AGENT AND TEST AGENT FOR DISEASE WITH MYOCARDIAL NECROSIS

Assay for cardiac troponin-T (cTnT)

Biomarkers and assays for myocardial infarction

Methods for assessing modified LDL immune complexes in subjects having or at risk of coronary artery disease

Marker Detection for Characterizing the Risk of Cardiovascular Disease or Complications thereof

USE OF PROCALCITONIN (PCT) IN PROGNOSIS FOLLOWING ACUTE CORONARY SYNDROMES

Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4

Methods of predicting and treating adverse cardiac events

Highly sensitive system and method for analysis of troponin

Biomarkers

MOLECULAR SIGNATURE FOR FIBROSIS AND ATROPHY

Methods for detecting cardiac damage

VASCULAR MARKERS IN THE REMODELING OF CARDIAC INJURY

H-FABP AS A MARKER FOR MYOCARDIAL HIBERNATION

CLASSIFICATION OF INDIVIDUALS SUFFERING FROM CARDIOVASCULAR DISEASES ACCORDING TO SURVIVAL PROGNOSES AS FOUND BY MEASURING THE LEVELS OF BIOMARKER YKL-40

Uses of Lp-PLA2 in combination to assess coronary risk

CHEMICAL MODULATION OF ELECTRONIC AND MAGNETIC PROPERTIES OF GRAPHENE

Use of B-Type Natriuretic Peptide as a Prognostic Indicator in Acute Coronary Syndromes

Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof

IDENTIFYING SUSCEPTIBILITY OF A SUBJECT TO CARDIAC THERAPY BASED ON DETERMINATION OF A CARDIAC TROPONIN, SCD40L, AND C-REACTIVE PROTEIN

Future cardiac event biomarkers CCL3, CCL5 and CCL18

Biomarkers for prediction of major adverse cardiac events and uses thereof

FATTY ACID MARKERS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF CARDIOVASCULAR DISEASE

Prognostic Prediction Method for Acute Coronary Syndrome

METHOD FOR DIRECT DETECTION OF ISCHEMIA-MODIFIED ALBUMIN USING A PARTNER FOR BINDING TO AN ALDEHYDE DERIVATIVE RESULTING FROM THE PEROXIDATION OF LIPIDS IN BOUND FORM

Diagnosis and risk stratification using NT-proET-1

DNA fragment and use thereof

SOLUBLE FAS IN ACUTE CORONARY SYNDROMES DIAGNOSIS

METHOD FOR DIAGNOSING ACUTE CORONARY SYNDROME

Methods for improving the recovery of troponin I and T in membranes, filters and vessels

Biomarkers

Markers associated with arteriovascular events and methods of use thereof

Granzyme A and granzyme B diagnostics

Assay for cardiac troponin autoantibodies

GENE TARGETS IN ANTI-AGING THERAPY AND TISSUE REPAIR

Method of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease

Diagnostic methods for acute ischemic disease using activated hepcidin as an indicator

METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE

Highly sensitive system and methods for analysis of troponin

Myoglobin as early predictor of myocardial infarction

Marker for inflammatory conditions

Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease

USING GDF 15 TO ASSESS PATIENTS PRESENTING TO EMERGENCY UNITS

Methods of detection of factor XIa and tissue factor

Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization

Highly sensitive system and methods for analysis of troponin

Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac Disease

Method for determining inflammatory disease

Method and Apparatus for Analyzing Bioprocess Fluids

Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment

Tetranor PGDM: a biomarker of PGDsynthesis in vivo

NEW BIOMARKER FOR MONITORING DEVELOPMENT OF DISEASES AND ASSESSING THE EFFICACY OF THERAPIES

BNP(1-32) epitope and antibodies directed against said epitope

GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF

Methods for detecting coronary artery disease

PLATELET ACTIVATION MARKERS AS INDICATORS FOR ANTI-PLATELET THERAPY

Making a prognosis in cases of cardiac disease using a combination of markers

ASSESSING RISK OF CARDIAC INTERVENTION IN PATIENTS SUFFERING FROM STABLE CORONARY HEART DISEASE BASED ON GDF-15

Assessing heart failure in patients with atrial fibrillation using GDF-15 and natriuretic peptides

IL1RL-1 as a cardiovascular disease marker and therapeutic target

H-FABP as early predictor of myocardial infarction

Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP

Compositions and Methods for Modulation of ADAMTS13 Activity

Method of determining equine NT-proBNP

Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

METHODS OF DIAGNOSING CARDIOVASCULAR DISEASE

DIAGNOSIS AND RISK STRATIFICATION OF CARDIAC INSUFFICIENCY USING NEUROPHYSIN

Methods for Determining Collateral Artery Development in Coronary Artery Disease

Method of measuring PTX3 with high sensitivity

Methods for diagnosing and treating a heart condition in a patient

Risk stratification for acute coronary syndrome by determining copeptin

Fatty acid pattern analysis for predicting acute coronary syndrome

Predicting heart failure following myocardial infarction by protease and protease inhibitor profiling

Methods of identifying a subject having or at risk of having or developing coronary artery disease

Methods for early diagnosis of acute coronary syndrome

Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof

Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events

ISOLATED HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES AND METHODS AND KITS FOR DETECTING HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES

A Method And A Kit For Diagnosing Type 2 Diabetes, Metabolic Syndrome, Sub Clinical Atherosclerosis, Myocardial Infarct, Stroke Or Clinical Manifestations Of Diabetes

METHODS OF DETECTING AND TREATING MYOCARDIAL ISCHEMIA AND MYOCARDIAL INFARCTION

Method for determining health status by analyzing analytes

Apparatus for body fluid analysis using surface-textured optical materials

Method and apparatus for analyzing vitamin E in lipoproteins

Use of MRP 8/14 levels for discrimination of individuals at risk of acute coronary syndromes

Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4

Methods of diagnosing acute cardiac disorders using BNP-SP

METHODS AND ASSAYS TO ASSESS CARDIAC RISK AND ISCHEMIA

System and assay for detection of cardiac markers for assessing acute myocardial infarction

Mitochondrial markers of ischemia

METHODS FOR DIAGNOSIS OF ACUTE CORONARY SYNDROME

Biomarkers and assays for myocardial infarction

Method and kit for diagnosing acute myocardial infarction

Adiponectin for treatment of various disorders

METHOD FOR THE PREDICTION OF VASCULAR EVENTS AND THE DIAGNOSIS OF ACUTE CORONARY SYNDROME

Marker for inflammatory conditions

Methods for diagnosis of cardiovascular disease

Biological markers for longevity and diseases and uses thereof

PIGF and FLT-1 as Prognostic Parameters for Cardiovascular Diseases

Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease

Method and apparatus for detection of analyte using an acoustic device

Method and apparatus for therapeutic drug monitoring using an acoustic device

Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy

Ascorbic acid conjugates

Method for diagnosing cardiovascular diseases

DIAGNOSTICS AND THERAPEUTICS FOR RESTENOSIS

PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS

Differentiation of acute and chronic myocardial necrosis in symptomatic patients

Procedure for the determination of the activity of the protease which activates factor VII from protein solutions

Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD

Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)

Materials and methods for the detection of nitrated fibrinogen

BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery disease

CARDIOVASCULAR AUTOIMMUNE DISEASE PANEL AND METHODS OF USING SAME

Novel GPCR and methods of use of the same

Methods for monitoring patients for efficacy of an antiplatelet therapy regimen

ASSAY FOR CARDIAC TROPONIN AUTOANTIBODIES

CARDIBIOINDEX/CARDIBIOSCORE AND UTILITY OF SALIVARY PROTEOME IN CARDIOVASCULAR DIAGNOSTICS

Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment

Method of examining inflammatory disease and method of screening remedy for imflammatory disease

Methods of Detecting Myocardial Ischemia and Myocardial Infarction

Methods for assessing the risk for development of cardiovascular disease

Highly Sensitive System and Methods for Analysis of Troponin

Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease

Method of Distinguishing Among Type a and Type B Acute Aortic Dissection and Acute Myocardial Infraction and Kit For Distinguishment

Novel brain natriuretic peptide variants and methods of use thereof

Method, Intermediate Station and Central Control Unit For the Packet-Switched Data Transmission in a Self-Organizing Radio Network

Method of preparing heart muscle cells and method of searching for remedy for heart diseases

Diagnostic Agent For Ischemic Heart Disease Risk Group

USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES

Assay for cardiac troponin autoantibodies

Cardiac troponin as an indicator of coronary artery disease

Biomarkers for peripheral artery disease

PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS

Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic diseases

Markers associated with arteriovascular events and methods of use thereof

Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof

Methods for identifying patients with increased risk of an adverse cardiovascular event

Myeloperoxidase, a risk indicator for cardiovascular disease

MARKERS FOR DIFFERENTIAL DIAGNOSIS AND METHODS OF USE THEREOF

Diagnostic markers for ischemia

Method for Detecting the Risk of Cardiovascular Diseases Such as Acute Myocardial Infarction and Coronary Heart Disease By Analysing Defesin

Relevance of achieved levels of markers of systemic inflammation following treatment

Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles

Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements

Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention

DIFFERENTIALLY EXPRESSED GENES RELATED TO CORONARY ARTERY DISEASE

Method and apparatus for analyzing bioprocess fluids

Differentially Expressed Genes Related to Coronary Artery Disease

Use of soluble FLT-1 and its fragments in cardiovascular conditions

Human Obesity Susceptibility Gene and Uses Thereof

Methods for improving the recovery of troponin I and T in membranes, filters and vessels

Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease

Detection and determination of the stages of coronary artery disease

Methods of diagnosing atherosclerosis by measuring ApoCI

Measuring troponin antibodies to assess cardiovascular risk

Method and system for determining whether additional laboratory tests will yield values beyond a threshold level

Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease

Multidimensional mass spectrometry or serum and celluar lipids directly from biologic extracts

Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies

Diagnostic assay for stroke

Mitochondrial markers of ischemia

Method for diagnosing acute coronary syndrome

Secreted polypeptide species associated with cardiovascular disorders

Transgenic mice carrying the HP-2 gene and uses as models for vascular diseases

Secreted polypeptide species associatedwith cardiovascular disorders

Stabilization of cardiac troponin

Secreted polypeptide species reduced cardiovascular disorders

Uses of lp-pla2 in combination to assess coronary risk

Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same

Marker for inflammatory conditions

Detection of plasma ACE2

Method and apparatus for detecting estradiol and metabolites thereof using an acoustic device

Biomarkers and assays for myocardial infarction

Methods and apparatus for detecting bacteria using an acoustic device

Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels

Methods and apparatus for detecting viruses using an acoustic device

Coronary Endothelial Dysfunction

Mitochondrial markers of ischemia

Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof

Methods and kits for the diagnosis of acute coronary syndrome

Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles

PROXIMAL MARKERS OF ARTERIAL THROMBOSIS AND INFLAMMATION FOR RISK STRATIFICATION OF CORONARY HEART DISEASE

PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies

Serum biomarkers in ischaemic heart disease

Methods and apparatus for detecting cardiac injury markers using an acoustic device

Plasma polymerization of atomically modified surfaces

Diagnosis of acute myocardial, ischemic diseases

Pathogenic gene for coronary artery disease

Peptide-based immunization therapy for treatment of atherosclerosis

IL1RL-1 as a cardiovascular disease marker and therapeutic target

Methods of assessing endothelial dysfunction using acute transient responses following fat administration

Interleukin-13 as a cardiovascular disease marker

Methods of identification of biomarkers with mass spectrometry techniques

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease

Tissue inhibitor of metalloproteinase (TIMP) as a marker and predictor of cardiovascular disease and both cardiac and non-cardiac mortality

Method of potentiating inflammatory and immune modulation for cell and drug therapy

Apparatus and methods for risk stratification of patients with chest pain of suspected cardiac origin

Prevention and treatment of cardiovascular pathologies with tamoxifen analogues

Relevance of achieved levels of markers of systemic inflammation following treatment

Marker for inflammatory conditions

Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions

Myeloperoxidase, a risk indicator for cardiovascular disease

Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease

Methods of diagnosing cardiovascular disease

Immunoassay

Biological markers for longevity and diseases and uses thereof

Diagnostic markers of acute coronary syndrome and methods of use thereof

Diagnostic marker

Indirect detection of cardiac markers for assessing acute myocardial infarction

Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

Monitoring heart failure

Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment

Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment

Method for treating myolytic disease and method for screening antimyolytic agent

Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof

Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

Methods and materials for diagnosing unstable angina

Detection of acute myocardial infarction biomarkers

Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation

Use of cardiac hormones to assess risk of cardiovascular complication from volume overload

Multiparameter method of screening for atherosclerosis-related coronary heart disease or stroke

Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease

Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants

Growth factor therapy mobilization of stem cells into the peripheral blood

Marker for inflammatory conditions

Soluble transferrin receptor

Methods for diagnosis of cardiovascular disease

System and apparatus for body fluid analysis using surface-textured optical materials

Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment

Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction

Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

Diagnostic assay

Method for evaluating and treating hypertension

Assays and kits for detecting and monitoring heart disease

Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin

Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels

Plasma thermograms for diagnosis and treatment of acute myocardial infarction

Use of remnant lipoprotein in the treatment and prevention of cardiovascular disease